Jardiance 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VF5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,196
Award facts
- Contract value 100% obligated
- $17,196.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 16, 2026, to AmerisourceBergen Drug Corp (a subsidiary of Cencora, Inc.) by the Defense Logistics Agency, provides 90 tablets of Jardiance 10 mg at a ceiling value of $17,196.22 with firm fixed-price terms. The order is not set-aside and is expected to reach completion by January 20, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used to treat type 2 diabetes, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military healthcare systems.
This award is issued under AmerisourceBergen Drug Corp's parent company's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling delivery of an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and other federal healthcare programs. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements on a competitive basis makes it a critical vendor within the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7VF5?
SPE2DR26F7VF5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F7VF5 worth?
The government has obligated $17,196 on SPE2DR26F7VF5.
Is contract SPE2DR26F7VF5 an order under another contract?
Yes. SPE2DR26F7VF5 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VF5 competed?
The extent of competition for SPE2DR26F7VF5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award